Mallon PWG - Search Results

1

Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021.

Ryom L, De Miguel R, Cotter AG, Podlekareva D, Beguelin C, Waalewijn H, Arribas JR, Mallon PWG, Marzolini C, Kirk O, Bamford A, Rauch A, Molina JM, Kowalska JD, Guaraldi G, Winston A, Boesecke C, Cinque P, Welch S, Collins S, Behrens GMN; EACS Governing Board. Ryom L, et al. Among authors: mallon pwg. HIV Med. 2022 Sep;23(8):849-858. doi: 10.1111/hiv.13268. Epub 2022 Mar 25. HIV Med. 2022. PMID: 35338549 Free PMC article.

2

Atazanavir trough plasma concentration monitoring in a cohort of HIV-1-positive individuals receiving highly active antiretroviral therapy.

Winston A, Bloch M, Carr A, Amin J, Mallon PW, Ray J, Marriott D, Cooper DA, Emery S. Winston A, et al. J Antimicrob Chemother. 2005 Aug;56(2):380-7. doi: 10.1093/jac/dki235. Epub 2005 Jul 4. J Antimicrob Chemother. 2005. PMID: 15996972

3

The clinical pharmacology of antiretrovirals in development.

Winston A, Mallon PW, Boffito M. Winston A, et al. Expert Opin Drug Metab Toxicol. 2006 Jun;2(3):447-58. doi: 10.1517/17425255.2.3.447. Expert Opin Drug Metab Toxicol. 2006. PMID: 16863445 Review.

4

The safety, efficacy, and pharmacokinetic profile of a switch in antiretroviral therapy to saquinavir, ritonavir, and atazanavir alone for 48 weeks and a switch in the saquinavir formulation.

Winston A, Mallon PW, Satchell C, MacRae K, Williams KM, Schutz M, Law M, Cooper DA, Emery S. Winston A, et al. Clin Infect Dis. 2007 Jun 1;44(11):1475-83. doi: 10.1086/517507. Epub 2007 Apr 18. Clin Infect Dis. 2007. PMID: 17479946 Clinical Trial.

5

Platelet function and HIV: a case-control study.

Satchell CS, Cotter AG, O'Connor EF, Peace AJ, Tedesco AF, Clare A, Lambert JS, Sheehan GJ, Kenny D, Mallon PW. Satchell CS, et al. AIDS. 2010 Mar 13;24(5):649-57. doi: 10.1097/QAD.0b013e328336098c. AIDS. 2010. PMID: 20177361

6

High-density lipoprotein levels and 10-year cardiovascular risk in HIV-1-infected patients.

Cotter AG, Satchell CS, O'halloran JA, Feeney ER, Sabin CA, Mallon PW. Cotter AG, et al. AIDS. 2011 Mar 27;25(6):867-9. doi: 10.1097/QAD.0b013e32834507f0. AIDS. 2011. PMID: 21330909

7

Hyperlactataemia in HIV-infected subjects initiating antiretroviral therapy in a large randomized study (a substudy of the INITIO trial).

Feeney ER, Chazallon C, O'Brien N, Meiffrédy V, Goodall RL, Aboulker JP, Cooper DA, Yeni P, Mallon PW; INITIO Trial International Co-ordinating Committee. Feeney ER, et al. HIV Med. 2011 Nov;12(10):602-9. doi: 10.1111/j.1468-1293.2011.00934.x. Epub 2011 May 22. HIV Med. 2011. PMID: 21599820 Free article. Clinical Trial.

8

Increased platelet reactivity in HIV-1-infected patients receiving abacavir-containing antiretroviral therapy.

Satchell CS, O'Halloran JA, Cotter AG, Peace AJ, O'Connor EF, Tedesco AF, Feeney ER, Lambert JS, Sheehan GJ, Kenny D, Mallon PW. Satchell CS, et al. J Infect Dis. 2011 Oct 15;204(8):1202-10. doi: 10.1093/infdis/jir509. J Infect Dis. 2011. PMID: 21917893

9

HIV infection and bone disease: implications for an aging population.

Cotter AG, Mallon PW. Cotter AG, et al. Sex Health. 2011 Dec;8(4):493-501. doi: 10.1071/SH11014. Sex Health. 2011. PMID: 22127034 Review.

10

Therapeutic options for low bone mineral density in HIV-infected subjects.

Cotter AG, Mallon PW. Cotter AG, et al. Curr HIV/AIDS Rep. 2012 Jun;9(2):148-59. doi: 10.1007/s11904-012-0117-9. Curr HIV/AIDS Rep. 2012. PMID: 22528765

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

173 results

Search Page